Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7550029rdf:typepubmed:Citationlld:pubmed
pubmed-article:7550029lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C0021368lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C0303611lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C1708632lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C2702333lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C0205266lld:lifeskim
pubmed-article:7550029lifeskim:mentionsumls-concept:C1522485lld:lifeskim
pubmed-article:7550029pubmed:issue4lld:pubmed
pubmed-article:7550029pubmed:dateCreated1995-10-30lld:pubmed
pubmed-article:7550029pubmed:abstractTextIntact polyvalent human immune globulin (IgG) labeled with Tc-99m by a mild chemical method was investigated with animals infected with either S. aureus or E. coli in the thigh muscle. Focal infection was clearly visualized by Tc-99m IgG scintigraphy within 1 h postinjection. Tc-99m IgG appeared to be concentrated in the liver, spleen, kidneys and urinary bladder. It cleared rapidly via the kidneys resulting minimal of tissue background activity and high infection-to-normal organ ratios. At 24 h postinjection, the ratios of infectious lesion to blood, normal muscle and bone averaged 10:1, 23:1, and 24:1 for S. aureus infection vs 4:1, 9:1 and 9:1 for E. coli infection, respectively. Tc-99m labeled IgG also concentrated in terpentine-induced aseptic inflammatory lesion with a target-to-blood ratio of 4:1, bone 6:1 and normal muscle about 10:1. These findings suggest potential value of Tc-99m IgG as an imaging agent for the early detection of focal infection and inflammation.lld:pubmed
pubmed-article:7550029pubmed:languageenglld:pubmed
pubmed-article:7550029pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7550029pubmed:citationSubsetIMlld:pubmed
pubmed-article:7550029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7550029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7550029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7550029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7550029pubmed:statusMEDLINElld:pubmed
pubmed-article:7550029pubmed:monthMaylld:pubmed
pubmed-article:7550029pubmed:issn0969-8051lld:pubmed
pubmed-article:7550029pubmed:authorpubmed-author:WashT ATAlld:pubmed
pubmed-article:7550029pubmed:authorpubmed-author:EisenmanJ IJIlld:pubmed
pubmed-article:7550029pubmed:authorpubmed-author:WadeWWJrlld:pubmed
pubmed-article:7550029pubmed:issnTypePrintlld:pubmed
pubmed-article:7550029pubmed:volume22lld:pubmed
pubmed-article:7550029pubmed:ownerNLMlld:pubmed
pubmed-article:7550029pubmed:authorsCompleteYlld:pubmed
pubmed-article:7550029pubmed:pagination513-9lld:pubmed
pubmed-article:7550029pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:meshHeadingpubmed-meshheading:7550029-...lld:pubmed
pubmed-article:7550029pubmed:year1995lld:pubmed
pubmed-article:7550029pubmed:articleTitleDetection of acute infection/inflammation with Tc-99m labeled intact polyvalent human IgG.lld:pubmed
pubmed-article:7550029pubmed:affiliationDepartment of Radiology, Los Angeles County King-Charles R. Drew University of Sciences and Medicine, UCLA, School of Medicine 90059, USA.lld:pubmed
pubmed-article:7550029pubmed:publicationTypeJournal Articlelld:pubmed